TTOO vs. PFE
Compare and contrast key facts about T2 Biosystems, Inc. (TTOO) and Pfizer Inc. (PFE).
Performance
TTOO vs. PFE - Performance Comparison
Loading graphics...
TTOO vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TTOO T2 Biosystems, Inc. | -94.00% | -98.81% | -93.31% | -95.58% | -94.50% | -58.37% | 5.98% | -61.13% | -26.94% | -21.67% |
PFE Pfizer Inc. | 14.66% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
Fundamentals
TTOO:
$7.68M
PFE:
$62.58B
TTOO:
-$5.97M
PFE:
$44.01B
TTOO:
-$39.51M
PFE:
$15.10B
Returns By Period
In the year-to-date period, TTOO achieves a -94.00% return, which is significantly lower than PFE's 14.66% return. Over the past 10 years, TTOO has underperformed PFE with an annualized return of -84.90%, while PFE has yielded a comparatively higher 4.32% annualized return.
TTOO
- 1D
- 50.00%
- 1M
- -86.36%
- YTD
- -94.00%
- 6M
- -97.58%
- 1Y
- -99.76%
- 3Y*
- -98.13%
- 5Y*
- -96.72%
- 10Y*
- -84.90%
PFE
- 1D
- 1.12%
- 1M
- 1.56%
- YTD
- 14.66%
- 6M
- 14.02%
- 1Y
- 18.86%
- 3Y*
- -6.22%
- 5Y*
- -0.14%
- 10Y*
- 4.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TTOO vs. PFE — Risk / Return Rank
TTOO
PFE
TTOO vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T2 Biosystems, Inc. (TTOO) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TTOO | PFE | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.02 | 0.71 | -0.73 |
Sortino ratioReturn per unit of downside risk | 24.55 | 1.17 | +23.38 |
Omega ratioGain probability vs. loss probability | 4.87 | 1.15 | +3.73 |
Calmar ratioReturn relative to maximum drawdown | -1.00 | 1.32 | -2.31 |
Martin ratioReturn relative to average drawdown | -1.25 | 3.18 | -4.43 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| TTOO | PFE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.02 | 0.71 | -0.73 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | -0.01 | -0.04 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.06 | 0.18 | -0.24 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.06 | 0.26 | -0.33 |
Correlation
The correlation between TTOO and PFE is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
TTOO vs. PFE - Dividend Comparison
TTOO has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.13%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TTOO T2 Biosystems, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 6.13% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Drawdowns
TTOO vs. PFE - Drawdown Comparison
The maximum TTOO drawdown since its inception was -100.00%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for TTOO and PFE.
Loading graphics...
Drawdown Indicators
| TTOO | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -58.96% | -41.04% |
Max Drawdown (1Y)Largest decline over 1 year | -99.94% | -12.59% | -87.35% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | -58.96% | -41.04% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | -58.96% | -41.04% |
Current DrawdownCurrent decline from peak | -100.00% | -42.75% | -57.25% |
Average DrawdownAverage peak-to-trough decline | -83.41% | -17.33% | -66.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 79.69% | 6.13% | +73.56% |
Volatility
TTOO vs. PFE - Volatility Comparison
T2 Biosystems, Inc. (TTOO) has a higher volatility of 605.07% compared to Pfizer Inc. (PFE) at 6.75%. This indicates that TTOO's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| TTOO | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 605.07% | 6.75% | +598.32% |
Volatility (6M)Calculated over the trailing 6-month period | 1,058.50% | 18.50% | +1,040.00% |
Volatility (1Y)Calculated over the trailing 1-year period | 4,239.03% | 26.73% | +4,212.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 1,919.20% | 25.46% | +1,893.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 1,359.58% | 23.90% | +1,335.68% |
Financials
TTOO vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between T2 Biosystems, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities